Skip to content
WeighLab

CoreAge Rx vs Ivim Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Ivim Health

Provider comparison

Shoppers ready to commit to a multi-month program who want weekly check-ins, or insured shoppers who want help getting brand-name Wegovy or Zepbound covered.

Semaglutide / month
$149.99/mo6-month program, starting dose, medication and program fee, compounded
Tirzepatide / month
$207.99/mo6-month program, starting dose, medication and program fee, compounded
Index 61/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Ivim Health pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

CoreAge Rx has the higher Cost-Efficiency Index: 94/100 versus 61/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

CoreAge Rx
All 50 states
Ivim Health
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

CoreAge Rx

Ivim Health

Semaglutide / month
CoreAge Rx: $99/mo
Ivim Health: $149.99/mo6-month program, starting dose, medication and program fee, compounded
Tirzepatide / month
CoreAge Rx: $149/mo
Ivim Health: $207.99/mo6-month program, starting dose, medication and program fee, compounded
Semaglutide / year (modeled)
CoreAge Rx: $1,188
Ivim Health: $1,800
Tirzepatide / year (modeled)
CoreAge Rx: $1,788
Ivim Health: $2,496
State availability
CoreAge Rx: All 50 states
Ivim Health: Coverage not published
Oral / sublingual option listed
CoreAge Rx: Not listed
Ivim Health: Yes
Brand-name access listed
CoreAge Rx: Not confirmed
Ivim Health: Yes
Provider facts checked
CoreAge Rx: October 2026
Ivim Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

CoreAge Rx

Anyone who wants one flat monthly price they can plan a full year around, on either molecule, without signing a contract.

Reasons to consider it

  • One price at every dose: semaglutide is $99 from 0.25 mg up to 2.5 mg, and tirzepatide is $149 from 2.5 mg up to 15 mg
  • No membership fee, no insurance needed and no long-term contract, and the price you lock in at checkout stays put as your dose rises
  • If the doctor decides a prescription isn't right for you, CoreAge refunds the medication portion of your payment

What to weigh up

  • Some programs we track publish lower semaglutide prices. Compare billing terms, dose pricing and required fees before choosing.
  • You pay before the doctor reviews your case, and if you aren't approved the FAQ promises a 100% refund while the refund policy keeps a $50 to $100 consultation fee
  • All sales are final once medication ships, because state and federal law don't allow medication returns

Compounded drugs are not FDA-approved. Understand the medication options.

Check CoreAge Rx pricing Read the full CoreAge Rx review

Ivim Health

Shoppers ready to commit to a multi-month program who want weekly check-ins, or insured shoppers who want help getting brand-name Wegovy or Zepbound covered.

Reasons to consider it

  • Publishes six-month rates: compounded semaglutide $75 and tirzepatide $133 a month, plus the $74.99 monthly program fee
  • Also prescribes brand-name Wegovy, the Wegovy pill, Foundayo, Zepbound and others, with an insurance team that handles prior authorizations
  • Weekly app check-ins and refills timed to your plan, with dose adjustments by your provider

What to weigh up

  • Programs run one, two, four or six months, and the FAQ says you can't cancel once a program starts; leaving early can cost $50 or $100 per unshipped portion
  • No month-to-month price is published: the advertised rates are six-month rates, and the cost at a higher dose isn't shown
  • Doesn't name its pharmacy or list the states it serves

Regulatory note: the FDA issued a warning letter to Ivim Services LLC dba Ivim in February 2026. We still list and link to Ivim Health; you should know the letter is on the public record before you decide.

Compounded drugs are not FDA-approved. Understand the medication options.

Check Ivim Health pricing Read the full Ivim Health review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

CoreAge RxIvim Health
Normalized Cost/Month
CoreAge Rx:
93/100
Ivim Health:
62/100
Price Transparency
CoreAge Rx:
97/100
Ivim Health:
78/100
Nationwide Access
CoreAge Rx:
98/100
Ivim Health:
24/100
Formulation Options
CoreAge Rx:
84/100
Ivim Health:
95/100
Clinical Oversight
CoreAge Rx:
90/100
Ivim Health:
79/100
Contract Flexibility
CoreAge Rx:
95/100
Ivim Health:
20/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to CoreAge RxAlternatives to Ivim Health
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.